Europe’s medical devices industry sees a rise of 34.8% in deal activity in June 2019

15 July 2019 (Last Updated July 15th, 2019 14:19)

Europe’s medical devices industry sees a rise of 34.8% in deal activity in June 2019

Europe’s medical devices industry saw a rise of 34.8% in deal activity during June 2019, when compared with the last 12-month average, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

A total of 31 medical devices industry deals worth $645.78m were announced for the region in June 2019, against the 12-month average of 23 deals.

Of all the deal types, venture financing saw most activity in June 2019 with 18 transactions, representing a 58.1% share for the region.

In second place was M&A with 12 deals, followed by private equity deals with one transactions, respectively capturing a 38.7% and 3.2% share of the overall deal activity for the month.

In terms of value of deals, M&A was the leading category in Europe’s medical devices industry with $520.37m, while venture financing and private equity deals totalled $125.42m and $0m, respectively.

Europe medical devices industry deals in June 2019: Top deals

The top five medical devices deals accounted for 91.9% of the overall value during June 2019.

The combined value of the top five medical devices deals stood at $593.3m, against the overall value of $645.78m recorded for the month. The top announced medical devices deal tracked by GlobalData in June 2019 was Bracco Imaging’s $475m acquisition of Blue Earth Diagnostics.

In second place was the $72.94m venture financing of BioSerenity by BPI France, Dassault Systemes, IDInvest Partners and LBO France and in third place was Quanterix’s $22.5m acquisition of UmanDiagnostics.

The $17.08m stake acquisition of Acteon Group by Groupe FFP and Savaria’s acquisition of D-ansermed and Silvalea for $5.78m held fourth and fifth positions, respectively.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.